Adjuvant therapy of resectable rectal cancer Conference Paper

  


Author: Minsky, B. D.
Title: Adjuvant therapy of resectable rectal cancer
Conference Title: 30th World Congress of the International College of Surgeons
Abstract: Combined modality therapy is an integral component in the adjuvant management of rectal cancer. The standard adjuvant therapy for resectable T-3 and/or N-1-2 rectal cancer is pelvic radiation therapy plus 5-FU based chemotherapy. The Intergroup (INT) randomized trials INT 0114 and INT 0144 will help determine the ideal chemotherapeutic agents and their routes of administration in the post-operative setting. The National Surgical Adjuvant Breast and Bowel Project (NSABP) R-03 and INT 0147 randomized trials will compare the efficacy and functional results of the preoperative and post-operative combined modality therapy approaches.
Journal Title XXX World Congress of the International College of Surgeons
Volume: 1
Conference Dates: 1996 Nov 25-29
Conference Location: Kyoto, Japan
ISBN: 8832311259
Publisher: Monduzzi Editore  
Date Published: 1996-11-01
Start Page: 419
End Page: 434
Language: English
ACCESSION: WOS:A1996BH12F00070
PROVIDER: wos
Notes: Proceedings Paper -- XXXth Biennial Congress of the International-College-of-Surgeons -- NOV 25-29, 1996 -- KYOTO, JAPAN -- Int Coll Surgeons, Int Coll Surgeons, Japanese Sect, Sci Council Japan, Japan Surg Soc -- VIA FERRARESE 119/2, 40128 BOLOGNA, ITALY -- Source: Wos